- Home
- / Kanghong Pharmaceutical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Kanghong Pharmaceutical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
¥19.4
2024-10-29
Market Capitalization
¥17.5 B
2024-10-29
Revenue
¥4.5 B
FY, 2025
CreditSafe Score
?
Score changed on Jun 08, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| CNY | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.9B | 3.2B | 3.2B | 3.6B | 3.3B | 3.9B | 4.4B | 4.5B |
| Cost of goods sold | 228.5M | 263.8M | 329.7M | 354.6M | 388.0M | 438.4M | 466.5M | 465.4M |
| Gross profit | 2.6B | 3.0B | 2.9B | 3.2B | 3.0B | 3.5B | 3.9B | 4.1B |
| Gross profit margin, % | 92.1% | 91.8% | 89.9% | 90.0% | 88.4% | 88.8% | 89.4% | 89.8% |
| Operating expense total | 1.9B | 2.2B | 3.4B | 2.6B | 1.9B | 2.1B | 2.5B | 2.6B |
| Depreciation and amortization | 77.4M | 93.0M | 118.5M | 362.2M | 155.2M | 219.6M | 227.4M | 240.9M |
| EBITDA | 730.3M | 787.5M | (529.7M) | 552.7M | 1.0B | 1.3B | 1.5B | 1.5B |
| EBITDA margin, % | 25.4% | 24.5% | -16.3% | 15.6% | 30.6% | 33.8% | 33.2% | 32.9% |
| EBIT | 725.0M | 781.2M | (580.6M) | 332.7M | 947.3M | 1.1B | 1.2B | 1.3B |
| EBIT margin, % | 25.2% | 24.3% | -17.9% | 9.4% | 28.4% | 29.1% | 28.3% | 28.0% |
| Interest income | 43.6M | 32.7M | 25.9M | 35.1M | 45.1M | 52.5M | 62.9M | 53.3M |
| Interest expense | 502.0K | |||||||
| Pre tax profit | 799.5M | 835.2M | (519.5M) | 393.4M | 1.0B | 1.2B | 1.4B | 1.4B |
| Income tax expense | 104.5M | 117.0M | (249.7M) | (27.7M) | 164.5M | 202.8M | 175.5M | 210.6M |
| Net Income | 694.9M | 718.2M | (269.9M) | 421.1M | 865.8M | 1.0B | 1.2B | 1.1B |